Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Jiangsu Simcere Pharmaceutical Co., Ltd.

Clinical trials sponsored by Jiangsu Simcere Pharmaceutical Co., Ltd., explained in plain language.

Jiangsu Simcere Pharmaceutical Co., Ltd. 2096 HKEX

Pharmaceutical company developing innovative drugs, subsidiary of Simcere.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 7 Not yet recruiting 2 Not yet finished but already full! 3 Completed 2 Terminated 1

New cancer drug tested in 13 patients – early trial ends

Disease control Terminated

This early-stage trial tested a new drug called SIM0501, alone or with another drug (olaparib), in 13 adults with advanced solid tumors that had stopped responding to standard treatments. The main goals were to check safety and how the drug moves through the body. The study was s…

Phase: PHASE1 • Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 09:03 UTC